Emergent BioSolutions Inc. (EBS)

Pharmaceutical Preparations

Latest Price

$6.67

TTM P/E

Normalized P/E

TTM Div Yield

Fwd Div Yield

Book Value

6.62

P/B Ratio

1.01

Valuation metrics

EPS: $0.93

Book value / share: $10.03

Formula: √(22.5 × EPS × BVPS)

Graham Number

$14.49

+117% upside

Norm. op. income: $100M (median of 7yr)

Tax rate: 28%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$6.44

3% downside

Base FCF: $96M (median of recent 5yr)

Growth: 25%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$129.90

+1848% upside

EPS: $0.93

Target P/E: 15×

Formula: EPS × P/E

P/E Fair Value

$13.95

+109% upside

82.7% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	4.72M	$39.0M	9.19%	+375.1K	2026-06-30
Dimensional Fund Advisors LP	3.08M	$25.0M	6.00%	+319.5K	2026-06-30
State Street Corp	2.93M	$24.0M	5.71%	+79.5K	2026-06-30
American Century Companies Inc	2.77M	$23.0M	5.40%	+344.7K	2026-06-30
Vanguard Capital Management LLC	2.20M	$18.0M	4.29%	-59.2K	2026-06-30
Lsv Asset Management	1.70M	$14.0M	3.31%	+799.2K	2026-06-30
Geode Capital Management, LLC	1.34M	$11.0M	2.61%	+64.3K	2026-06-30
Charles Schwab Investment Management Inc	1.20M	$10.0M	2.34%	-305.3K	2026-06-30
Sixth Street Partners Management Company, L.P.	1.20M	$10.0M	2.34%	--	2026-06-30
Oak Hill Advisors LP	1.11M	$9.0M	2.17%	--	2026-06-30